ALPS Medical Breakthroughs ETF
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SBIO and other ETFs, options, and stocks.About SBIO
SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.
Index-TrackedBloomberg US 1000 TR USD
Index-TrackedBloomberg US 1000 TR USD
CategoryHealth
CategoryHealth
Number of holdings105
Number of holdings105
Inception DateDec 30, 2014
Inception DateDec 30, 2014
What's in this fund
Sectors
As of December 5, 2025Healthcare100.00%
Top 10 Holdings (30.99% of total assets)
As of December 5, 2025NameSymbol% Assets
Avidity BiosciencesRNA4.42%
Arrowhead PharmaceuticalsARWR3.50%
CytokineticsCYTK3.24%
Axsome TherapeuticsAXSM3.19%
Rhythm PharmaceuticalsRYTM3.02%
MerusMRUS2.96%
NuvalentNUVL2.95%
Krystal BiotechKRYS2.74%
PTC TherapeuticsPTCT2.49%
VaxcytePCVX2.48%
SBIO Key Statistics
AUM112.06M
AUM112.06M
Price-Earnings ratio-19.35
Price-Earnings ratio-19.35
30-Day yield-0.45
30-Day yield-0.45
Average volume47.62K
Average volume47.62K
High today$51.87
High today$51.87
Low today$50.56
Low today$50.56
Open price$51.45
Open price$51.45
Volume36.56K
Volume36.56K
52 Week high$51.87
52 Week high$51.87
52 Week low$22.33
52 Week low$22.33
Expense ratio0.50
Expense ratio0.50
Stock Snapshot
As of today, ALPS Medical Breakthroughs ETF(SBIO) shares are valued at $51.60. The company's market cap stands at 114.85M, with a P/E ratio of -19.35.
On 2025-12-08, ALPS Medical Breakthroughs ETF(SBIO) stock moved within a range of $50.56 to $51.87. With shares now at $51.60, the stock is trading +2.1% above its intraday low and -0.5% below the session's peak.
Trading volume for ALPS Medical Breakthroughs ETF(SBIO) stock has reached 36.56K, versus its average volume of 47.62K.
The stock's 52-week range extends from a low of $22.33 to a high of $51.87.
The stock's 52-week range extends from a low of $22.33 to a high of $51.87.